NFKB1 and rheumatoid arthritis: contain important bioactive compounds that play a role in the treatment of RA by inhibiting the release of inflammatory factors and inhibiting the expression of TRP family protein to reduce the expression of IL-1β, IL-6, TNF-α, and VEGF inflammatory proteins and further inhibit the expression of NF-κB protein in synovial tissue.